PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.38 +0.31 (+1.54%)
As of: Sep 11, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Net Equity Issued and Repurchased (2021 - 2024)

PROCEPT BioRobotics' (PRCT) quarterly Net Equity Issued and Repurchased came in at $164.5 million in Q4 2024, up 12863.62% quarter-over-quarter from -$1.3 million in Q3 2022.

Analysis

PROCEPT BioRobotics (PRCT) Net Equity Issued and Repurchased (2021 - 2024) Analysis & Trends

PROCEPT BioRobotics (PRCT) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $164.5 million the latest figure, recorded in Q4 2024.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $164.5 million in Q4 2024; TTM through Dec 2024 was $163.2 million, a 12763.62% increase from a year earlier, with the FY2024 full-year figure at $164.5 million, up 1.74% from the prior year.
  • Net Equity Issued and Repurchased was $164.5 million for Q4 2024 at PROCEPT BioRobotics, up from -$1.3 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $164.5 million in Q4 2024 and troughed at -$1.3 million in Q3 2022.
  • A 3-year average of $82.7 million and a median of $85.0 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn -
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn -
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 20.00 Mn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn -
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn -
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn -
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn -
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn -
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn -
10 PROCEPT BioRobotics 1.17 Bn 895.36 Mn 62.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 164.52 Mn
Sep 30, 2022 -1.29 Mn
Jun 30, 2021 85.00 Mn